Constipation Treatment

Global Constipation Treatment Market to Reach US$27.5 Billion by 2030

The global market for Constipation Treatment estimated at US$19.5 Billion in the year 2024, is expected to reach US$27.5 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the Chloride Channel Activators segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.1 Billion While China is Forecast to Grow at 8.9% CAGR

The Constipation Treatment market in the U.S. is estimated at US$5.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Constipation Treatment Market – Key Trends & Drivers Summarized

Why Is There Increasing Demand for Constipation Treatment Solutions?
The growing prevalence of gastrointestinal disorders, particularly constipation, is driving demand for treatment solutions globally. Factors such as aging populations, sedentary lifestyles, poor dietary habits, and increasing levels of stress contribute to rising incidences of constipation, especially in developed regions. Moreover, constipation is a common side effect of medications used to treat chronic conditions like pain, hypertension, and diabetes. This has led to an increasing need for effective over-the-counter (OTC) laxatives, prescription medications, and natural remedies to alleviate symptoms and improve patients` quality of life.

How Are Technological and Pharmaceutical Innovations Impacting Constipation Treatment?
Pharmaceutical companies are continuously innovating to develop more effective and patient-friendly treatment options for constipation. Recent advancements include the development of novel laxatives with fewer side effects, such as osmotic laxatives, as well as medications like prokinetics that stimulate intestinal motility. Additionally, the rise of probiotics and fiber supplements as natural alternatives for managing constipation is gaining popularity, particularly among health-conscious consumers. Innovations in drug delivery mechanisms, such as extended-release formulations, are also helping to enhance treatment efficacy and patient compliance.

Which Demographic Segments Are Leading the Demand for Constipation Treatment?
The elderly population is a significant driver of demand for constipation treatments, as aging often leads to slower digestive function and increased reliance on medications that may cause constipation. Additionally, patients with chronic illnesses, such as irritable bowel syndrome (IBS), are frequent consumers of constipation treatment products. The increasing awareness of gastrointestinal health among younger populations is also fueling demand for OTC laxatives, natural remedies, and dietary supplements. Healthcare professionals are increasingly recommending preventive measures, including lifestyle modifications, to address chronic constipation, further driving the use of treatment solutions.

What Are the Key Growth Drivers of the Constipation Treatment Market?
The growth in the constipation treatment market is driven by several factors, including the increasing prevalence of gastrointestinal disorders, the growing aging population, and the rise in demand for OTC medications. The expanding awareness of digestive health and the rising trend toward self-medication are also boosting the demand for natural and OTC treatment options. Pharmaceutical advancements, such as the development of novel drugs with fewer side effects and more targeted action, are further contributing to market growth. Additionally, the increasing focus on preventive healthcare and lifestyle management is driving the adoption of dietary supplements and probiotics.

SCOPE OF STUDY:

The report analyzes the Constipation Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Disease Type (Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome with Constipation (IBS-C), Opioid-Induced Constipation (OIC)); Therapeutic Option (Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C Agonists, 5-HT4 Receptor Agonists)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Abbott
• AbbVie`s Inc.
• Albireo Pharma, Inc.
• AstraZeneca
• Bausch Health Companies Inc.
• Bayer AG
• Cosmo Pharma
• Daewoong
• Ironwood Pharmaceuticals
• Janssen Pharmaceutical
• Mallinckrodt Plc
• Prestige Brands
• Renexxion
• Sanofi
• Shionogi
• Takeda Pharmaceutical Company Limited

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.